NCT04910126 2021-06-02Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue SarcomaUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2 Unknown84 enrolled